Search
for
Sort by
Research 271–300 of 1000+
- Clinical Features and Treatment Options of Vogt-Koyanagi-Harada Disease
- Prolonged Drug-Induced Hypersensitivity Syndrome/DRESS With Alopecia Areata and Autoimmune Thyroiditis
- When JAK inhibitors are off the table: durable remission of severe alopecia areata with dexamethasone oral mini-pulse and a focused review
- Current Diagnostic and Therapeutic Practices in Alopecia Areata in Two Mediterranean Countries: A Survey-Based Study
- Hormonal interventions in skin wounds – a mini review
- The JAK/STAT signaling pathway: from bench to clinic
- Insulin-like growth factor 1 and hair growth
- Ruxolitinib protects skin stem cells and maintains skin homeostasis in murine graft-versus-host disease
- Inhibition of 17α-hydroxylase/C17,20 lyase reduces gating deficits consequent to dopaminergic activation
- Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine
- Delivery of nanocarriers with dissolvable microneedles for skin treatments: Approaches and challenges
- Increased CRHR1 expression on monocytes from patients with AA enables a pro‐inflammatory response to corticotrophin‐releasing hormone
- Acne Syndromes and Mosaicism
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Insulin-like Growth Factor 1 (IGF-1) in Hair Regeneration: Mechanistic Pathways and Therapeutic Potential
- Comparison of Current International Guidelines for the Management of Alopecia Areata—Comprehensive Review
- A Single Subcutaneous Dose of BMD-1141 Stimulates Hair Regrowth Comparable to Daily, High-Dose Ruxolitinib in a Mouse Model of Alopecia Areata.
- Revolutionizing psoriasis care: Microneedle innovations in treatment and diagnosis
- Recipient site scalp necrosis: A rare postoperative complication of hair transplantation
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Impaired wound healing in transgenic mice overexpressing the activin antagonist follistatin in the epidermis
- Bimatoprost in the treatment of eyelash hypotrichosis
- Chemotherapy-induced alopecia in mice. Induction by cyclophosphamide, inhibition by cyclosporine A, and modulation by dexamethasone.
- Growth of wool follicles in culture
- Tissue Resident Foxp3+ Regulatory T Cells: Sentinels and Saboteurs in Health and Disease
- Apoptosis in Hair and Skin: A Review
- Stem-cell therapy in dermatology – Challenges and opportunities
- Age-dependent endocrine disorders involved in the pathogenesis of refractory acne in women
- INTERFERONS IN DERMATOLOGY
- Adherence to topical hydrocortisone 17-butyrate 0.1% in different vehicles in adults with atopic dermatitis